Cardax Profit Margin

Cardax (CDXI) currently reports a profit margin of -1534.21% as of March 2021. That compares with -785.21% in the prior-year period — down 95.4% year over year. That is below the Healthcare sector average of 9.71%. Use the charts on this page to explore Cardax's profit margin history and peer comparisons.

Cardax's profit margin decreased from -785.21% to -1534.21% — a 95.4% year-over-year decrease (period ending March 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cardax's profit margin of -1534.21% is lower than the Healthcare sector average of 9.71%. That is roughly 15906.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Cardax's current -1534.21% should be judged against Healthcare norms (sector average: 9.71%) and against CDXI's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1534.21%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.71%. From there, open related valuation or income-statement pages for Cardax, and consider following CDXI for alerts when major investors trade the stock.